eToro: Buy Shares with 0% Commission

Your capital is at risk

How to Buy Synairgen Shares With 0% Commission

Synairgen deals is a top biotech company based in the UK. The recent breakthrough in its development of the respiratory drug SNG001 has seen the company attract interest from several investors. This guide shows you How to Buy Synairgen Shares UK while paying 0% in commissions and why this could be an ideal moment to buy shares of the biotech company.

How to Buy Synairgen Shares UK – Step by Step Guide 2021

If you are in haste and want to buy shares in Synairgen UK, then these quickfire steps should get you started in no time. The eToro platform is our preferred broker due to its low fees and feature-rich functionalities. To get started, follow the steps below:

Step 1: Open an account with eToro – Head to eToro’s official website and click on ‘Join Now.’ Fill in a valid email address, username, and password.
Step 2: Upload ID – Upload a copy of your ID (driver’s license or official passport) and proof of address (bank statement or utility bill) as proof of identity.
Step 3: Deposit Funds – You can make a minimum deposit of $50 via bank wire transfer, PayPal, credit card, debit card, and several other options.
Step 4: Buy Synairgen Shares UK – Type the ticker symbol into the search bar and click the ‘Trade’ button. Enter the amount you want to invest and click ‘Open Trade’ to get started.

Step 1: Choose A Broker

You need to select a broker before buying Synairgen shares. This is an important step as stock brokers generally serve as intermediaries to the financial markets, enabling buyers and sellers to interact.
However, you need to select a broker with guaranteed security, regulatory coverage, low fees, and an overall great trading experience. This section covers two of our carefully reviewed top brokers to buy Synairgen shares UK.

1. eToro – Overall Best Broker to Buy Synairgen Shares in the UK

eToro stock brokereToro is a social trading platform founded in 2007 and is highly popular with the global trading community. Boasting over 20 million active users, eToro offers exposure to 17 international markets, touching 3,000 global shares, commodities, bonds, ETFs, CFDs, cryptocurrencies, and FX currency pairs.

The best thing about using eToro to buy Synairgen shares is that you can trade several asset classes commission-free. This means you only pay for the underlying asset. Another useful feature is the CopyTrade which has made the platform so popular.

etoro copyportfolio

With this, you can copy successful traders and profit even if you are a new trader. It also supports an in-house managed CopyPortfolio, enabling you to diversify your investment across several regions and sectors. As regards its user experience, eToro offers a top-notch service through its web platform and mobile app. Mobile users also get the same full functionality as the web option with the added benefit of trading while on the move. eToro does not charge monthly fees, making it easier for you to capitalize on your investments fully. Also, you can buy up fractions or parts due to eToro’s ‘fractional shares’ offering. It also supports several payment methods, and you can make deposits with bank transfer, credit/debit card, or e-wallet providers like PayPal.


  • Commission-free trades
  • No stamp duty for UK shares
  • Low minimum deposit bar of $50
  • Regulated by the FCA, ASIC, CySEC, and FinCEN
  • Feature-rich platform with CopyTrade and CopyPortfolio functionality
  • Over 3,000 global shares in 17 international markets


  • Receives deposits in Dollars only
  • Small withdrawal and inactivity fees

67% of retail investor accounts lose money when trading CFDs with this provider.

2. Fineco Bank – Buy Synairgen Shares UK with Leverage

Fineco ETF brokerOur second platform to buy Synairgen shares in the UK is Italy-based Fineco Bank. Operating traditionally as a conventional bank, Fineco offers financial trading services. Founded in 1997, Fineco is a leading broker with more than a decade in facilitating financial transactions in the stock market.

It’s regulated by the UK’s FCA and the Italian Market Authority (CONSOB). This makes it a safe platform to trade securely. Meanwhile, Fineco offers contracts for differences (CFDs) trades, and you can easily trade Synairgen shares without necessarily holding the asset.

fineco bank review

Leveraged trades are also offered on Fineco as you can get up to 1:30 for FX currency pairs, 1:20 for commodities like gold, indices, and several minor FX pairs. Leverage is set at 1:5 for stocks, and you can short-sell your assets anytime you need. Fineco offers investors a large exposure for stock trading, ETFs, and other investment assets.

It does not charge for deposits and monthly fees and offers low-cost trades with no extra hidden fees. You also enjoy no inactive or withdrawal fees.
Like eToro, you can either trade on Fineco’s web trading platform or use the mobile app.


  • No inactivity or withdrawal fees
  • No deposit or monthly fees
  • Large trading products on offer
  • Heavily regulated by the FCA and CONSOB


  • Supports only bank deposits only
  • Serves only UK and Italian clients

67% of retail investor accounts lose money when trading CFDs with this provider. 

Step 2: Research Synairgen Shares

Synairgen’s Interferon-beta treatment for Covid-19 patients is a major boon for the company. The likelihood of this inhaled formulation has seen several investors buy Synairgen shares. However, before taking such a step, you need to understand where the company is coming from and where it is headed. This would likely give you an insight if its share price may likely rise in the future.

Given the important role research plays in determining a company’s future potential performance, we have highlighted some key details, including its stock market performance and its top-performing respiratory drug. This will guide you in deciding whether to buy Synairgen shares or not.

What is Synairgen?


Synairgen logo

Synairgen is a leading Southampton-based biotechnology company. It is a drug and development company founded by University of Southampton Professors Sir Stephen Holgate, Donna Davies, and Ratko Djukanovic. It was founded in 2003, and the company specializes in developing treatments for respiratory diseases like severe asthma and COPD, alongside Covid-19.

Since the outbreak of the Wuhan-generated illness in early 2020, Synairgen has focused on finding a cure or stop-gap measures in addressing the viral spread of the respiratory infection. This led the biotech company down the path to SNG001 or inhaled interferon beta, currently undergoing clinical trial.

synairgen homepage

According to the Southern England biotech giant, its interferon-beta treatment was conducted in a double-blind, placebo-controlled trial that saw 101 Covid patients from nine specialist hospitals taking the drug. The company said that patients who were administered SNG001 had a 79% lower risk of developing severe diseases than those who received a placebo. Those who got the interferon drug were twice more likely to recover from Covid-19 complications than those who were fed dummy drugs.

Also, the average time patients spent in hospitals were significantly reduced by a third – down from an average of nine days to six days. Interferon beta is one of the first defenses against viral diseases as it warns the body against an attack. According to the Synairgen team, its treatment is inspired by the body’s immune structure. SARS-CoV-2 penetrates the body by suppressing its production, thereby reducing the victim’s response to infection.

Synairgen biobank

SNG001 seeks to boost this primary line of defense by delivering interferon-beta directly to the patient’s airways through a nebulizer which turns the protein into an aerosol. This is meant to trigger a stronger anti-viral response, even in patients whose immune systems have been severely hampered by respiratory disease. So far, SNG001 has undergone various clinical trials and is peer-reviewed on The Lancet Respiratory Medicine Journey. It has also been effective against Covid variants, particularly the UK and South Africa morphs. But its patient base is still minimal, and this has seen its approval delayed.

However, the Chief Scientist in charge of the trial, Tom Wilkinson, believes in the efficacy of the treatment for patients with severe respiratory issues. According to him, if the results are confirmed in larger studies, then the treatment will be a “game-changer” for the fight against the Wuhan-like respiratory illness. Explaining further the intricacies behind the SNG001 project, Wilkinson said,
“This pH neutral, inhaled interferon beta-1a formulation (SNG001) provides high, local concentrations of immune protein which boosts lung defenses rather than targeting specific viral mechanisms. This might carry additional advantages of treating Covid-19 when it occurs alongside infection by another respiratory virus such as Influenza or Respiratory Syncytial Virus that may well be encountered in the winter months.”

Synairgen Share Price

Synairgen’s share price has been wildly impacted by the announcement of its game-changing Covid treatment. At press time, Synairgen share price is currently trading at £145.20. This shows a 37.58% drop by £87.41 in the last year. However, the SNG stock has not been performing badly since it launched on the London Stock Exchange trading floor (LSE).

Synairgen price charts August 17

67% of retail investor accounts lose money when trading CFDs with this provider.

It had a somewhat lackluster performance from 2017 to 2019, trading below the £50 price target, only making the semblance of an uptrend in 2017 when it climbed to 35.79 GBX.
2020 presented a pivotal year for the company, with the UK-based biotech company catching the eye of investors when it announced the results of its SNG001 tests on over 100 severely affected patients. This saw it shoot up 500% from its December 2019 low of £7.58 to £61.63 in early April 2020. After losing steam, Synairgen became an overnight success when it surged to 246.53 on August 21, 2020. It subsequently dipped, moving below the £200 mark but has mainly retained its price average above £130.

Despite its intra-day dip of 37.58%, Synairgen has posted massive returns for investors averaging an astounding 305.70% growth in stock value in the last five years.
Its recent foray and breakthrough in respiratory illness treatments, especially for Covid-19, could see it become one of the leading biotech companies in the world.

Synairgen Shares Dividends

Some investors buy into a company’s stock due to the passive revenue in dividend payments they can earn from holding its stock. However, Synairgen does not offer share dividends for investors at the moment. Much like many unprofitable companies, Synairgen is going through its cash burn phase. With over three years still left to exhaust its burn ratio, Synairgen could still steer its ship into good waters in the event of a successful launch and approval of its SNG001 in the coming months. As per future dividend payments, we are still in the dark concerning this and will likely update if there are any changes.

Synairgen ESG Breakdown

Environmental, social, and governance (ESG) factors are becoming increasingly important in investors’ decisions in the last few years. Now, companies are scrutinized for their environmental impact to know if they have been meticulous in running their operations. To help us understand how Syanirgen performs in this vital asset score, we need to carry out an ESG rating with CSR Hub.

Data below shows the biotech company’s ESG awareness:

  • Environmental – 63/100
  • Social – 51
  • Governance – 49

As depicted from the listing, Synairgen scores well above average for its environmental factors and are in the middle in the social and government aspect. Given these factors, Synairgen shares can be a great investment if you are an ESG-conscious investor.

Are Synairgen Shares A Good Buy?

So, will it be a good decision to buy Synairgen shares in the UK today? Before taking this step, be aware that a company’s growth is mainly based on several circumstances and is not set in stone. This means it may go up or down. Another thing you should also keep at the back of your mind is if the company’s services make it a sustainable business for the long term.

However, two things work in Synairgen’s favor. First is its share price, which has shown remarkable growth in the last two years. It has grown more than 1,000% since dipping to £7.58 in late 2019. Its current valuation of £145.2 shows that investors are keen on buying Synairgen shares despite not making any profit yet.

This is evident in 2020 when several businesses were shut down due to the economic crash. Synairgen continued to post strong returns reaching its all-time high during the toughest period of the human fight against viral infections. Another is its phenomenal breakthrough in the treatment of the global pandemic. Biotech companies are becoming increasingly attractive to companies, especially if they are involved in the Covid-19 fight. Synairgen’s SNG001 is a phenomenal solution, and its efficacy in older patients could see it become adopted by over 750 million senior citizens in the world. If it comes out successful in larger studies, it could propel the company into a unicorn status.

Step 3: Open an Account and Buy Shares

The first step is to create an account with a top broker. We recommend using the popular social trading platform eToro as a case study to show you how to buy Synairgen shares in ten minutes without paying any commissions.

Step 1: Create an eToro account

To do this, visit the eToro official homepage and click on the ‘Join Now’ button on your right-hand side to open the signup page. You will need to provide a username, valid email address and select a strong, unique password.

etoro open account

67% of retail investor accounts lose money when trading CFDs with this provider.

Step 2: Verify your Identity

eToro is regulated by the UK’s FCA and several other top bodies. This means you will need to complete a compulsory KYC process as part of your onboarding process. Do not worry. It only takes a couple of minutes, and you can complete it all online. Click on the ‘Complete Profile’ icon on the bottom of your dashboard and upload a copy of your driver’s license or official passport and a copy of your proof of address (a recent copy of your bank statement or utility bill is enough). Your documents will be verified within minutes, and you can head down to the next stage.

Step 3: Make a Deposit

To buy Synairgen shares UK, you will need to make a minimum deposit of $50 on your eToro account. eToro supports multiple payment options, and you can choose to pay through any of the following methods:

  • Bank transfer
  • Credit card
  • Debit card
  • PayPal
  • Skrill
  • Neteller
  • Klarna
  • Trustly

Deposit funds on eToro with credit card, PayPal, e-wallet.

67% of retail investor accounts lose money when trading CFDs with this provider.

Step 4: Buy Shares

Once the deposit is complete, you can now invest in any shares you want. To do this, type in the ticker symbol of the asset into the search tool on the dashboard. Click ‘Trade’ on the asset you want to invest in. You will be taken to an order box where you enter the amount you want to invest. You can also use leverage to increase your potential returns. However, make sure you put a take-profit (TP) and stop-loss (SL) to limit your exposure to the asset. Once you are satisfied, you can click on ‘Open Trade’ to get started.

Synairgen Shares Buy or Sell?

So, should you buy or sell Synairgen shares? It all depends on what you think of the company’s future potential success. However, its limited test success shows the potential the SNG001 holds.
If you are searching for a platform to buy Synairgen shares in the UK, we suggest trying out the eToro platform. eToro does not support SNG trading at the moment, but you can easily take positions in the best biotech companies on the platform. eToro is home to over 20 million active traders. Boasting a global presence in 17 international markets, you can effortlessly trade over 3,000 global shares, commodities, FX currency pairs, ETFs, CFDs, and cryptocurrencies. All these trades can be executed commission-free, meaning you don’t have to pay for any commission aside from the underlying asset. In addition, if you are new to the financial market, eToro allows you to make profits while minimizing capital loss through the CopyTrade functionality. This will enable you to copy successful trades from more experienced traders. eToro is also feature-rich and promotes an overall satisfying trading experience.

eToro – Buy Synairgen Shares with 0% Commission

Synairgen is a leading biotechnology company based in the UK. As with other companies in the sector, Synairgen’s share price had been positively impacted by the coronavirus. Over the last 12 months, the company’s share has grown from 76.5 p to about 250.45 pence. The company’s inhaled drug SNG001 has proved a major success so far, despite not being a vaccine. To buy Synairgen shares UK and shares of other large biotech firms, we recommend eToro. eToro offers investors over 800 stock trading options, FX pairs, commodities, and other financial instruments. The platform is easy to use, has a multitude of trading options and allows for commission-free trading.

etoro logo

67% of retail investor accounts lose money when trading CFDs with this provider. 


Are Synairgen shares a good buy?

Where can I buy Synairgen shares?

Who owns the most Synairgen shares?

How much do Synairgen shares cost?

Are Synairgen shares risky?

About Jimmy Aki PRO INVESTOR

Based in the UK, Jimmy is an economic researcher with outstanding hands-on and heads-on experience in Macroeconomic finance analysis, forecasting and planning. He has honed his skills having worked cross-continental as a finance analyst, which gives him inter-cultural experience. He currently has a strong passion for regulation and macroeconomic trends as it allows him peek under the global bonnet to see how the world works.

Read next